MALIGNANT HYPERTENSION IN A CHILD WITH HEMOLYTIC-UREMIC SYNDROME TREATED WITH CAPTOPRIL

1 July 1981

journal article
research article
Published by Wiley in Acta Paediatrica

Vol. 70 (4) , 583-585
https://doi.org/10.1111/j.1651-2227.1981.tb05747.x

Abstract

A 5 yr old boy is presented suffering from malignant hypertension due to hemolytic-uremic syndrome. Captopril, an oral angiotensin-1-converting enzyme inhibitor, was able to curb the natural course of the malignant hypertension. Hemodialysis could be discontinued after 2 mo. The glomerular filtration rate recovered to 63 ml/min per 1.73 m2 11 mo. after the acute phase.

Keywords

This publication has 10 references indexed in Scilit:

IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL
The Lancet, 1980
CAPTOPRIL AND AGRANULOCYTOSIS
The Lancet, 1980
CAPTOPRIL ASSOCIATED GRANULOCYTOPENIA IN HYPERTENSION AFTER RENAL TRANSPLANTATION
The Lancet, 1980
REVERSIBLE RENAL-FAILURE IN MALIGNANT HYPERTENSION
1980
Use of the oral angiotensin I-converting enzyme inhibitor(captopril) in childhood malignant hypertension
The Journal of Pediatrics, 1979
CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE
The Lancet, 1979
Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults
Kidney International, 1979
The Hemolytic Uremic Syndrome
Pediatric Clinics of North America, 1976
Effect of Antihypertensive Drugs on the Renin-Angiotensin System
Drugs, 1976
The Hemolytic-Uremic Syndrome
Nephron, 1973